Gulf HIV Clinical Forum 2019 – Enduring Materials

 

Monday 2 December 2019

 Session 1 - Integrase Inhibitors as part of clinical management of PLWH
Chairs: Bandar Alamri & Charles Boucher
 

Bhagani, Sanjay 2014_120Attributes of INSTIs as a first line treatment option
Sanjay Bhagani, BSc, FRCP - Royal Free Hospital, London, UK

 

 

Paredes, Roger  2016 120Two versus three drugs - what are the data?
Roger Paredes, MD, PhD - Hospital Germans Trias i Pujol, Barcelona, Spain

 

 

Boucher, Charles 2017Integrase inhibitor resistance: does it matter?
Charles Boucher, MD, PhD - Erasmus Medical Center, Rotterdam, the Netherlands

 

 

Wali, Ghassan 2018 120x160Optimal use of INSTIs in KSA
Ghassan Wali, MD, FRCP(C) - King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia

 

  
 Session 2 - Factors affecting the choice of antiretroviral therapy
Chairs: Sanjay Bhagani & Ghassan Wali
 

Paredes, Roger  2016 120Switching ARV therapy - clinical and resistance considerations
Roger Paredes, MD, PhD - Hospital Germans Trias i Pujol, Barcelona, Spain

 

 

Calcagno, Andrea 120 x 160Switching ARV therapy - clinical and pharmacological considerations
Andrea Calcagno, MD, DTM&H - University of Torino, Torino, Italy

 

 

Waters, Laura 2016ARV toxicity and their management (including weight gain)
Laura Waters, MD - Central & North West London NHS Trust, London, UK

 

  
 Session 3 - Optimal ARV treatment in special populations
Chairs: Roger Paredes & Abdulla Baradwan
 

Bhagani, Sanjay 2014_120Antiretroviral therapy in pregnancy: Risks and benefits
Sanjay Bhagani, BSc, FRCP - Royal Free Hospital, London, UK

 

 

Alhazmi, Mohammad 120x160Antiretroviral therapy in HIV-TB co-infected patients
(Not available)
Mohammad Alhazmi, MD, FACP - King Fahad Central Hospital Jizan, Jizan, Kingdom of Saudi Arabia

 

Ali, Batool_2019 120x160Breast feeding in HIV
(No permission to publish slides or video)
Batool Ali, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia

 

Waters, Laura 2016Clinical case
(No permission to publish slides or video)

Laura Waters, MD - Central & North West London NHS Trust, London, UK

  
 Session 4 - ARV treatment options in the near future
Chairs: Bandar Alamri & Charles Boucher
 

Calcagno, Andrea 120 x 160Novel treatment options - Long Acting Antiretroviral compounds
Andrea Calcagno, MD, DTM&H - University of Torino, Torino, Italy

 

 

Alamri, Bandar_2019 120x160Reducing HIV stigma and promoting early diagnosis
Bandar Alamri, MD - East Jeddah Hospital, Jeddah, Kingdom of Saudi Arabia